KARSTEN MAEDER,RAINER EUGEN MARTIN,SUSANNE RAAB,LUKAS CHRISTOPH SCHEIBLER,THOMAS SCHINDLER,MARCO SCHROEDER
申请号：
MYPI 20022058
公开号：
MY161871A
申请日:
2002.06.04
申请国别(地区):
MY
年份:
2017
代理人:
摘要：
THE PRESENT INVENTION RELATES TO A PHARMACEUTICAL COMPOSITION COMPRISING A LIPASE INHIBITOR, PREFERABLY ORLISTAT, HAVING A MELTING POINT ≥ 37°C, A SUCROSE FATTY ACID ESTER WHEREIN THE SUCROSE FATTY ACID ESTER IS A MONO-, DI-, TRI- OR TETRA-ESTER, AND OPTIONALLY ONE OR MORE PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS.
